{
    "2021-12-14": [
        [
            {
                "time": "",
                "original_text": "年内险企股权更迭频繁，中小险企成交易‘主力军’，外资布局势头迅猛",
                "features": {
                    "keywords": [
                        "险企",
                        "股权更迭",
                        "中小险企",
                        "外资布局"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "人福医药：实际控制人艾路明累计增持公司股份约25万股",
                "features": {
                    "keywords": [
                        "人福医药",
                        "实际控制人",
                        "艾路明",
                        "增持"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "人福医药实控人艾路明累计增持0.02%股份，增持金额525.79万元",
                "features": {
                    "keywords": [
                        "人福医药",
                        "实控人",
                        "艾路明",
                        "增持",
                        "金额"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "人福医药(600079.SH)实控人艾路明增持25.06万股",
                "features": {
                    "keywords": [
                        "人福医药",
                        "实控人",
                        "艾路明",
                        "增持",
                        "股数"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}